Gastric cancer treatment: recent progress and future perspectives
WL Guan, Y He, RH Xu - Journal of hematology & oncology, 2023 - Springer
Gastric cancer (GC) is one of the most common malignancies worldwide. Most patients are
diagnosed at advanced stages due to the subtle symptoms of earlier disease and the low …
diagnosed at advanced stages due to the subtle symptoms of earlier disease and the low …
Signaling pathways and therapeutic interventions in gastric cancer
Gastric cancer (GC) ranks fifth in global cancer diagnosis and fourth in cancer-related death.
Despite tremendous progress in diagnosis and therapeutic strategies and significant …
Despite tremendous progress in diagnosis and therapeutic strategies and significant …
[HTML][HTML] Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach
TH Kim, IH Kim, SJ Kang, M Choi, BH Kim… - Journal of gastric …, 2023 - ncbi.nlm.nih.gov
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …
is the 4th gastric cancer guideline published in Korea which is the revised version of …
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
FH Wang, XT Zhang, YF Li, L Tang, XJ Qu… - Cancer …, 2021 - Wiley Online Library
There exist differences in the epidemiological characteristics, clinicopathological features,
tumor biological characteristics, treatment patterns, and drug selections between gastric …
tumor biological characteristics, treatment patterns, and drug selections between gastric …
[HTML][HTML] Updates on global epidemiology, risk and prognostic factors of gastric cancer
WJ Yang, HP Zhao, Y Yu, JH Wang, L Guo… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Gastric cancer (GC) is defined as the primary epithelial malignancy derived from the
stomach, and it is a complicated and heterogeneous disease with multiple risk factors …
stomach, and it is a complicated and heterogeneous disease with multiple risk factors …
Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
R Liu, J Wu, H Guo, W Yao, S Li, Y Lu, Y Jia… - MedComm, 2023 - Wiley Online Library
Histones are DNA‐binding basic proteins found in chromosomes. After the histone
translation, its amino tail undergoes various modifications, such as methylation, acetylation …
translation, its amino tail undergoes various modifications, such as methylation, acetylation …
Interventional gastroenterology in oncology
Cancer is one of the foremost health problems worldwide and is among the leading causes
of death in the United States. Gastrointestinal tract cancers account for almost one third of …
of death in the United States. Gastrointestinal tract cancers account for almost one third of …
Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trial
J Xu, H Jiang, Y Pan, K Gu, S Cang, L Han, Y Shu, J Li… - JAMA, 2023 - jamanetwork.com
Importance Gastric and gastroesophageal junction cancers are diagnosed in more than 1
million people worldwide annually, and few effective treatments are available. Sintilimab, a …
million people worldwide annually, and few effective treatments are available. Sintilimab, a …
Exosomes: another intercellular lipometabolic communication mediators in digestive system neoplasms?
S Li, R Dong, Z Kang, H Li, X Wu, T Li - Cytokine & growth factor reviews, 2023 - Elsevier
Neoplasms are one of the most concerned public health problems worldwide. Digestive
system neoplasms, with a high morbidity and mortality, is one of the most common malignant …
system neoplasms, with a high morbidity and mortality, is one of the most common malignant …
[HTML][HTML] Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer
Y Kubota, A Kawazoe, S Mishima, Y Nakamura… - ESMO open, 2023 - Elsevier
Background We conducted comprehensive clinical and molecular characterization of
claudin 18.2 expression (CLDN18. 2) in advanced gastric or gastroesophageal junction …
claudin 18.2 expression (CLDN18. 2) in advanced gastric or gastroesophageal junction …